Canopy Growth Corp (NYSE: CGC) announced a multiyear advanced manufacturing agreement with Colombia’s Procaps S.A.S. Monday as part of a broader update on its operations worldwide.
South American Developments
Canopy said it will leverage Procaps’ encapsulation capacity. Canopy is licensed to produce THC or CBD on over 13.5 million square feet of space in Colombia.
The Canopy subsidiary Spectrum Therapeutics has completed sales to patients in Chile and Brazil, the company said.
Canopy said it plans to launch a CBD product line where rules allow.
Need more cannabis news? Check out all of our coverage here.